Minerva Neurosciences
NERV
21 hedge funds and large institutions have $3.34M invested in Minerva Neurosciences in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
1% more capital invested
Capital invested by funds: $3.31M → $3.34M (+$31.8K)
0.12% less ownership
Funds ownership: 27.93% → 27.81% (-0.12%)
5% less funds holding
Funds holding: 22 → 21 (-1)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$20.3K |
| 2 |
AC
Apella Capital
West Hartford,
Connecticut
|
+$513 |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$178 |
| 4 |
Jones Financial Companies
Des Peres,
Missouri
|
+$93 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$41 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 2 |
Renaissance Technologies
New York
|
-$5.06K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$3.29K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.81K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.22K |
NERV Hedge Fund Activity: Q2 2025 in Review
21 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2025, worth a combined $3.34M — up 0.96% from $3.31M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NERV and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.
The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $20.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $22K sold.
- 21 institutional investors held Minerva Neurosciences (NERV) as of Q2 2025, down from 22 in Q1 2025.
- Funds reported $3.34M of Minerva Neurosciences stock for Q2 2025, up 0.96% quarter-over-quarter.
- 3 funds opened new Minerva Neurosciences positions in Q2 2025 and 4 closed out, a net change of -1 holder.
- The largest Minerva Neurosciences buyer in Q2 2025 was ADAR1 Capital Management, an estimated $20.3K added.
- The largest Minerva Neurosciences seller in Q2 2025 was Citadel Advisors, an estimated $22K sold.
Based on aggregated 13F filings for Q2 2025.